Introducing BSN medical Australia and New Zealand
Wednesday, 04 May, 2016
We are pleased to announce that BSN medical in Australia and New Zealand has commenced operations as a new, local organisation to service and support our customers. We have a head office in Melbourne and a comprehensive support network across Australia and New Zealand.
This means that the local supply of BSN medical products, previously managed by Smith & Nephew, will now be managed by us directly.
What does this mean for you?
First, we will continue to supply the brands you know and trust – which include Leukoplast®, JOBST®, Gypsona®, Swann-Morton® and Fixomull®.
We also look forward to introducing new, advanced products designed to broaden clinical choice, help manage healthcare budgets and improve patient and consumer outcomes. With a global focus on continuous technological advancement, we will continue to add to our family of best-in-class products spanning each therapeutic area we serve.
Our Australian and New Zealand business retains the support of our global company – a world leader in the medical device sector, specialising in the areas of orthopaedics, vascular therapy and wound management. Our focus is on therapies that work together across the entire treatment lifecycle. These ‘integrated therapy solutions’ are designed to serve throughout the course of a patient’s injury or condition.
To put it another way, we aim to be more than just a product provider for a specific problem. Our goal is to help make a meaningful difference in the lives of patients who require specialist wound care, compression therapy or joint support due to illness or injury.
We are excited about our new journey, and we look forward to working with you more closely.
icalIf you have any questions or would like more information, please contact us using one of these options. Call 1300 BSN MED (1300 276 633) or email customerservice.au@bsnmedical.com or visit www.bsnmedical.com.au or post to PO Box 337, Mount Waverley Victoria 3149.
Tool to predict risk of sudden cardiac arrest
A new gene mutation-specific test will help predict the severity of heart arrhythmia that could...
Surrogacy linked to higher risk of pregnancy complications: study
The risk of complications is higher in gestational carriers or pregnancy surrogates compared with...
Are triptans more effective for acute migraines?
While there are numerous drugs available for migraines, there's no clear consensus on which...